US2012027865A1PendingUtilityA1
Water Dispersible Glyceryl Monooleate Magnetic Nanoparticle Formulation
Est. expiryMay 21, 2029(~2.8 yrs left)· nominal 20-yr term from priority
A61K 33/26A61K 9/14A61K 9/5115A61K 9/5192A61K 31/231A61K 9/5094A61K 49/1866B82Y 5/00A61K 49/1836A61K 49/1869Y10S977/911Y10S977/773Y10S977/906A61K 9/5123A61K 9/0009A61K 49/1839A61K 41/0052
53
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention is an aqueous dispersible magnetic nanoparticle formulation with a high drug loading capacity used for sustained drug delivery. The formulated magnetic nanoparticles are composed of an iron oxide core coated with a long chain polymer, which provides aqueous dispersibility without the use of surfactant. A method is developed for the functionalization of magnetic nanoparticles for use in biomedical field.
Claims
exact text as granted — not AI-modified1 . A water dispersible glyceryl monooleate (GMO) magnetic nanoparticle (MNP) formulation comprising an iron oxide particle core coated with a long chain polymer for producing an aqueous dispersible magnetic nanoparticle formulation.
2 . The glyceryl monooleate magnetic nanoparticle formulation as claimed in claim 1 , further comprising one or more therapeutic agents or a functional group.
3 . The glyceryl monooleate magnetic nanoparticle formulation as claimed in claim 2 , wherein said therapeutic agent is selected from hydrophobic and hydrophilic agents.
4 . A method for preparing glyceryl monooleate (GMO) magnetic nanoparticles (MNPs) formulation comprising:
heating a mixture of Fe (III) and Fe (II) with constant stirring under N 2 atmosphere; adding ammonium hydroxide to the said mixture; adding glyceryl monooleate (GMO) to the suspension drop wise; subjecting the mixture to the step of stirring under N 2 atmosphere; washing the formulation several times with different solvents to wash the excess glyceryl monooleate (GMO); and subjecting the washed formulation to the step of lyophilization to yield powder form.
5 . The method as claimed in claim 4 , wherein the mixture is heated at 80° C.
6 . The method as claimed in claim 4 , wherein 12-560 μl of GMO is added to get 10-504% of GMO coated MNPs.
7 . The method as claimed in claim 4 , wherein the mixture is stirred for 20 minutes at 80° C. under N 2 atmosphere to evaporate excess ammonia from the formulation.
8 . The method as claimed in claim 4 , wherein the solvent is ethyl acetate:acetone (70:30).
9 . The method as claimed in claim 4 , wherein the formulation is sonicated for 2 minutes at 55 watt.
10 . The method as claimed in claim 4 , wherein the step of washing with different solvents further comprises centrifugation for 20 minutes at 10° C. at 20,000 rpm.
11 . The method as claimed in claim 4 , wherein said solvents are selected from acetone, ethyl acetate, diethyl ether, chloroform, and mixtures of different solvents in different ratios like ethyl acetate:acetone (50:50 and 70:30).
12 . The method as claimed in claim 4 , wherein the step of washing is repeated for 3 times.
13 . The GMO-MNP formulation as claimed in claim 1 , wherein the glyceryl monooleate (GMO) magnetic nanoparticles (MNPs) formulation is a carrier for a hydrophilic or hydrophobic drug.
14 . The GMO-MNP formulation as claimed in claim 1 used in biomedical field such as cell separation.
15 . The GMO-MNP formulation as claimed in claim 2 , wherein the functional group is attached to one of a protein or a targeting moiety.Join the waitlist — get patent alerts
Track US2012027865A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.